American International Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,664
| Closed | -$2.09M | – | 3054 |
|
|
2022
Q3 | $2.09M | Buy |
30,664
+1,494
| +5% | +$82.4K | 0.02% | 927 |
|
|
2022
Q2 | $932K | Sell |
29,170
-1,585
| -5% | -$46.4K | 0.01% | 1243 |
|
|
2022
Q1 | $1.06M | Sell |
30,755
-2,164
| -7% | -$64.7K | 0.01% | 1296 |
|
|
2021
Q4 | $964K | Buy |
32,919
+161
| +0.5% | +$4.99K | ﹤0.01% | 1456 |
|
|
2021
Q3 | $835K | Sell |
32,758
-778
| -2% | -$22.9K | ﹤0.01% | 1534 |
|
|
2021
Q2 | $1.17K | Buy |
33,536
+32,205
| +2,420% | +$1.26M | ﹤0.01% | 1427 |
|
|
2021
Q1 | $54 | Sell |
1,331
-159
| -11% | -$7.31K | ﹤0.01% | 2966 |
|
|
2020
Q4 | $65 | Sell |
1,490
-41
| -3% | -$2.02K | ﹤0.01% | 2869 |
|
|
2020
Q3 | $84K | Sell |
1,531
-70
| -4% | -$4.45K | ﹤0.01% | 2624 |
|
|
2020
Q2 | $101K | Sell |
1,601
-32,692
| -95% | -$2.24M | ﹤0.01% | 2537 |
|
|
2020
Q1 | $1.75M | Sell |
34,293
-1,982
| -5% | -$133K | 0.01% | 922 |
|
|
2019
Q4 | $2.88M | Sell |
36,275
-305
| -0.8% | -$18.1K | 0.01% | 899 |
|
|
2019
Q3 | $1.77M | Buy |
36,580
+1,961
| +6% | +$102K | 0.01% | 1024 |
|
|
2019
Q2 | $1.82M | Buy |
34,619
+479
| +1% | +$27.5K | 0.01% | 1039 |
|
|
2019
Q1 | $1.81M | Buy |
34,140
+1,243
| +4% | +$61.1K | 0.01% | 1035 |
|
|
2018
Q4 | $1.35M | Sell |
32,897
-252
| -0.8% | -$9.44K | 0.01% | 1119 |
|
|
2018
Q3 | $1.26M | Buy |
33,149
+598
| +2% | +$26.5K | ﹤0.01% | 1292 |
|
|
2018
Q2 | $1.47M | Buy |
32,551
+7,654
| +31% | +$349K | 0.01% | 1154 |
|
|
2018
Q1 | $1.2M | Buy |
24,897
+28
| +0.1% | +$1.56K | ﹤0.01% | 1168 |
|
|
2017
Q4 | $979K | Buy |
24,869
+117
| +0.5% | +$4.37K | ﹤0.01% | 1384 |
|
|
2017
Q3 | $769K | Buy |
24,752
+1,850
| +8% | +$52K | ﹤0.01% | 1509 |
|
|
2017
Q2 | $626K | Buy |
22,902
+12,871
| +128% | +$383K | ﹤0.01% | 1548 |
|
|
2017
Q1 | $370K | Buy |
10,031
+1,945
| +24% | +$49K | ﹤0.01% | 1810 |
|
|
2016
Q4 | $117K | Sell |
8,086
-22
| -0.3% | -$387 | ﹤0.01% | 2511 |
|
|
2016
Q3 | $187K | Buy |
8,108
+12
| +0.1% | +$229 | ﹤0.01% | 2213 |
|
|
2016
Q2 | $134K | Buy |
8,096
+4,131
| +104% | +$83.3K | ﹤0.01% | 2402 |
|
|
2016
Q1 | $63K | Buy |
+3,965
| New | +$70.5K | ﹤0.01% | 3742 |
|
Other funds holding GBT
American International Group's GBT Position: Q4 2022 in Review
American International Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 30,664 shares — an estimated $2.09M sold.
American International Group first reported a position in GBT in Q1 2016 and held it in 27 quarters. The position peaked at $2.88M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- American International Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- American International Group sold 30,664 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.09M.
- American International Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 27 quarters.
- American International Group's Global Blood Therapeutics, Inc. position peaked at $2.88M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.